The new Fred Hutchinson rebranding ad campaign juxtaposes clinical care and research.
October 7, 2022 01:43 PM EDTUpdated 05:00 PM
Pharma
Marketing

Fred Hutch re­brands af­ter merg­er, blend­ing can­cer re­search and pa­tient care lega­cies in new iden­ti­ty

Beth Snyder Bulik

Senior Editor

When Fred Hutchin­son Can­cer Re­search Cen­ter and Seat­tle Can­cer Care Al­liance merged, it was a mar­riage of com­ple­men­tary strengths for the al­ready close part­ners. How­ev­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times